Longevitytech.fund to resume fundraising in early September

The fund aims to hold a second close on $2-3m by February 2021 and to raise the remainder within a year, Sramek said. It could potentially raise more than $10m if the firm sees enough opportunities, he added. 

The fund raised $1m from high-net-worth individuals in the Czech Republic earlier this year in a first closing, Sramek said, with the next rounds now opened up to international investors and institutional investors. 

It has already attracted interest from new investors around the world, including several institutional investors, and some of the existing investors have expressed interest in re-upping for subsequent closes, Sramek added.

Longevitytech.fund currently has four companies in its portfolio and aims to invest in a total of up to 30 companies in the longevity space over the next two years, Sramek said. This includes companies in the biotech, ageing diagnostics, AI, agetech, regenerative therapies, wealthtech and fintech fields that are developing technologies related to improving and extending lifespans. 

It will invest in pre-seed, seed and series-A rounds and plans to participate in follow-up rounds with some of its companies too, Sramek said. It largely co-invests in rounds with other investors.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• CEE
• Technology
• Venture
• Exclusive